Company summary & AIM Rule 26 information
Main Page Content
| Primary Country Listing | UK |
|---|---|
| Status | AIM |
| Index | |
| Sector | Chemicals |
| Activities | Investment company |
| EPIC | BIP |
| Overview from Annual Report | 31/12/2007 | 31/12/2006 |
|---|---|---|
| Ave. No. Employees (Excl. Directors) | 2 | 0 |
| Total Employee Cost | £0.115m | £0m |
| Gearing | -31.35% | -29.94% |
| ROCE | -3.43% | -3.89% |
| Latest Results - Interim | 30/06/2008 |
|---|---|
| Turnover (£m) | 0 |
| Pre-tax profit (£m) | -0.14 |
| EPS (undiluted and pre-exceptionals p) | -0.1 |
| Dividend (p) | 0 |
| Notes | Figures from 2006 in accordance with IFRS. |
| Closing Share Price (p) | 1.75 | |
|---|---|---|
| Number of Shares in Issue (m) | 151.06 | |
| Market Capitalisation(£m) | 2.64 | |
The information below is being disclosed for the purposes of AIM Rule 26 and was last updated on 10 March 2008.
- Description of our business
- Directors
- Responsibilities of the members of the board of directors and details of committees
- Country of incorporation and main country of operation
- Our current constitutional documents:
-
Biofutures Articles of Association (August 2008, 260 kB pdf)
-
- Biofutures International plc has not applied or agreed to have any of its securities (including its AIM securities) admitted or traded any other exchanges or trading platforms
- The number of AIM securities in issue and the percentage of AIM securities not in public hands together with the identity and percentage holdings of its significant shareholders: Major shareholders
- There are no restrictions on the transfer of Biofutures International plc's AIM securities
- Notifications made in past 12 months
- Our most recent admission document:
-
Biofutures Admission Document (October 2006, 847 kB pdf)
-
- Details of our nominated adviser and other key advisers
